TRUEBLUE INC (TBI) Stock Analyst Ratings
NYSE:TBI - US89785X1019 - Common Stock
6.19 USD
+0.02 (+0.32%)
6.19 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 80% to TBI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.84. This target is 42.81% above the current price.
TBI was analyzed by 7 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about TBI.
In the previous month the buy percentage consensus was at a similar level.
TBI was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-06 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-11-05 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-08-07 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-06-17 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-05-08 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-05-07 | Baird | Maintains | Outperform -> Outperform |
| 2023-07-26 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-05-22 | BMO Capital | Upgrade | Market Perform -> Outperform |
| 2023-04-26 | BMO Capital | Maintains | Market Perform |
| 2023-04-25 | Baird | Maintains | Outperform |
| 2022-07-27 | BMO Capital | Maintains | Market Perform |
| 2022-07-26 | Baird | Maintains | Outperform |
| 2022-05-26 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2021-04-27 | Baird | Upgrade | Neutral -> Outperform |
| 2021-04-27 | Credit Suisse | Maintains | Neutral |